# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-050684
Filing Date
2022-04-27
Accepted
2022-04-27 08:00:42
Documents
4
Period of Report
2022-06-09

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | tm223678-1_def14a.htm | DEF 14A | 704729
2 | GRAPHIC | sg_jillmilne-bw.jpg | GRAPHIC | 7184
3 | GRAPHIC | tm223678d1-pxy_proxy1bw.jpg | GRAPHIC | 991841
4 | GRAPHIC | tm223678d1-pxy_proxy2bw.jpg | GRAPHIC | 1123935
| Complete submission text file | 0001104659-22-050684.txt |  | 3625703

Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37467 | Film No.: 22856409
SIC: 2834 Pharmaceutical Preparations